ActoFactor™ Recombinant Human High mobility group AT-hook 2 from Creative Bioarray

Supplier Page

Supplier Page from
Creative Bioarray for
ActoFactor™ Recombinant Human High mobility group AT-hook 2

Description

Human LeukinFeron is a natural cytokine involved in cellular reactions elimination of pathogen (antigen). Treatment with LeukinFeron results in a reduced frequency of side effects caused by prospidine therapy. Human LeukinFeron in the combined therapy of Kaposis sarcoma leads to a considerable improvement of the initially abnormal levels of immunocompetent and phagocytizing cells. LeukinFeron is a complex preparation of human cytokines from the first phase of the immune response, containing 10,000 IU of natural IFN-alpha and other cytokines at their natural ratio, mainly IL6, IL12, TNF-alpha, MIF, and LIF. The preparation is obtained from donors blood leukocytes